Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2004 Feb 23;177(2):634–645. doi: 10.1016/0042-6822(90)90529-Z

Genetics of mouse hepatitis virus transcription: Identification of cistrons which may function in positive and negative strand RNA synthesis

Mary C Schaad ∗, Stephen A Stohlman †, James Egbert †, Karen Lum ∗, Kaisong Fu ∗, Theodore Wei Jr †, Ralph S Baric ∗,1
PMCID: PMC7131749  PMID: 2164727

Abstract

A panel of 26 temperature-sensitive mutants of MHV-A59 were selected by mutagenesis with either 5-fluorouracil or 5-azacytidine. Complementation analysis revealed the presence of one RNA+ and five RNA− complementation groups. None of the RNA− complementation groups transcribed detectable levels of positive- or negative-stranded RNA at the restrictive temperature. Temperature shift experiments after the onset of mRNA synthesis revealed at least two classes of RNA− mutants. RNA− complementation groups A, B, D, and E were blocked in the ability to release infectious virus and transcribe mRNA and genome, while group C mutants continued to release infectious virus and transcribe both mRNA and genome. Temperature shift experiments at different times postinfection suggest that the group C mutants encode a function required early in viral transcription which affects the overall rate of positive strand synthesis. Analysis of steady state levels of negative strand RNA after the shift indicate that the group C mutants were probably blocked in the ability to synthesize additional minus strand RNA under conditions in which the group E mutants continued low levels of minus strand synthesis. These data suggest that at least four cistrons may be required for positive strand synthesis while the group C cistron functions during minus strand synthesis.

References

  1. Armstrong J., Niemann H., Smeekens S., Rottier P., Warren G. Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus. Nature (London) 1984;308:751–752. doi: 10.1038/308751a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baker S., Shieh C.-K., Soe L.H., Chang M.-F., Vannier D.M., Lai M.M.C. Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein. J. Virol. 1989;63:3693–3699. doi: 10.1128/jvi.63.9.3693-3699.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baric R.S., Stohlman S.A., Lai M.M.C. Characterization of replicative intermediate RNA of mouse hepatitis virus: Presence of leader RNA sequences on nascent chains. J. Virol. 1983;48:633–640. doi: 10.1128/jvi.48.3.633-640.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baric R.S., Stohlman S.A., Razavi M.K., Lai M.M.C. Characterization of leader-related small RNAs in coronavirus infected cells: Further evidence for leader-primed mechanism of transcription. Virus Res. 1985;3:19–33. doi: 10.1016/0168-1702(85)90038-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Baric R.S., Shieh C.-K., Stohlman S.A., Lai M.M.C. Analysis of intracellular small RNAs of mouse hepatitis virus: Evidence for discontinuous transcription. Virology. 1987;156:342–354. doi: 10.1016/0042-6822(87)90414-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baric R.S., Nelson G.W., Fleming J.O., Deans R.J., Keck J.G., Casteel N., Stohlman S.A. Interactions between coronavirus nucleocapsid protein and viral RNAs: Implications for viral transcription. J. Virol. 1988;62:4280–4287. doi: 10.1128/jvi.62.11.4280-4287.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Baric R.S., Fu K.S., Schaad M.C., Stohlman S.A. Establishing a genetic recombination map for murine coronavirus strain A59 complementation groups. Virology. 1990;177:646–656. doi: 10.1016/0042-6822(90)90530-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boursnell M.E.G., Brown T.D.K., Foulds I.J., Green P.F., Tomley F.M., Binns M.M. Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus. J. Gen. Virol. 1987;68:57–77. doi: 10.1099/0022-1317-68-1-57. [DOI] [PubMed] [Google Scholar]
  9. Brayton P.R., Lai M.M.C., Patton C.D., Stohlman S.A. Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J. Virol. 1982;42:847–853. doi: 10.1128/jvi.42.3.847-853.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brayton P.R., Stohlman S.A., Lai M.M.C. Further characterization of mouse hepatitis virus RNA-dependent RNA polymerases. Virology. 1984;133:197–201. doi: 10.1016/0042-6822(84)90439-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brierly I., Boursnell M.E.G., Binns M.M., Bilimoria B., Blok V.C., Brown T.D.K., Inglis S.C. An efficient ribosomal frame-shifting signal in the polymerase-encoding region of the coronavirus IBV. EMBO J. 1987;6:3779–3785. doi: 10.1002/j.1460-2075.1987.tb02713.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Compton S.R., Rogers D.B., Holmes K.V., Fertsch D., Remenick J., McGowan J.J. In vitro replication of mouse hepatitis virus strain A59. J. Virol. 1987;61:1814–1820. doi: 10.1128/jvi.61.6.1814-1820.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Denison M.R., Perlman S. Translation and processing of mouse hepatitis virus virion RNA in a cell-free system. J. Virol. 1986;60:12–18. doi: 10.1128/jvi.60.1.12-18.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Denison M.R., Perlman S. Identification of a putative polymerase gene product in cells infected with murine coronavirus A59. Virology. 1987;157:565–568. doi: 10.1016/0042-6822(87)90303-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hahn Y.S., Garkovi A., Rice C.M., Strauss E.G., Strauss J.H. Mapping RNA− temperature sensitive mutants of sindbis virus: Complementation group F mutants have lesions in NSP4. J. Virol. 1989;63:1194–1202. doi: 10.1128/jvi.63.3.1194-1202.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hahn Y.S., Strauss E.G., Strauss J.H. Mapping of the RNA− temperature-sensitive mutants of sindbis virus: Assignment of complementation groups A, B and G to nonstructural proteins. J. Virol. 1989;63:3142–3150. doi: 10.1128/jvi.63.7.3142-3150.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Keck J.G., Stohlman S.A., Soe L., Making S., Lai M.M.C. Multiple recombination sites at the 5′ end of murine coronavirus RNA. Virology. 1987;156:331–341. doi: 10.1016/0042-6822(87)90413-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Keck J.G., Hogue B.G., Brian D.A., Lai M.M.C. Temporal regulation of bovine coronavirus RNA synthesis. Virus Res. 1988;9:343–356. doi: 10.1016/0168-1702(88)90093-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Keck J.G., Soe L.H., Making S., Stohlman S.A., Lai M.M.C. RNA recombination of murine coronaviruses: Recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J. Virol. 1988;62:1989–1998. doi: 10.1128/jvi.62.6.1989-1998.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Koolen M.J.M., Osterhaus A.D.M.E., Van Steenis G., Horzinek M.C., Van der Zeijstz B.A.M. Temperature sensitive mutants of mouse hepatitis virus strain A59: Isolation, characterization and neuropathogenic properties. Virology. 1983;125:393–402. doi: 10.1016/0042-6822(83)90211-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lai M.M.C., Stohlman S.A. RNA of mouse hepatitis virus. J. Virol. 1978;26:236–242. doi: 10.1128/jvi.26.2.236-242.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lai M.M.C., Patton C.D., Stohlman S.A. Replication of mouse hepatitis virus: Negative-stranded RNA and replicative form RNA are of genome length. J. Virol. 1982;44:487–492. doi: 10.1128/jvi.44.2.487-492.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lai M.M.C., Patton C.D., Baric R.S., Stohlman S.A. Presence of leader sequences in the mRNA of mouse hepatitis virus. J. Virol. 1983;46:1027–1033. doi: 10.1128/jvi.46.3.1027-1033.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lai M.M.C., Baric R.S., Brayton P.R., Stohlman S.A. Vol. 81. 1984. Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic virus; pp. 3626–3630. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lai M.M.C., Baric R.S., Making S., Keck J.G., Egbert J., Leibowitz J.L., Stohlman S.A. Recombination between nonsegmented RNA genomes of murine coronavirus. J. Virol. 1985;56:449–456. doi: 10.1128/jvi.56.2.449-456.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Leibowitz J.L., Wilhelmsen K.C., Bond C.W. The virus-specific intracellular RNA species of two murine coronaviruses: MHV-A59 and MHV-JHM. Virology. 1981;114:39–51. doi: 10.1016/0042-6822(81)90250-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Leibowitz J.L., DeVries J.R., Haspel M.V. Genetic analysis of murine hepatitis virus strain JHM. J. Virol. 1982;42:1080–1087. doi: 10.1128/jvi.42.3.1080-1087.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Luytjes W., Bredenbeek P.J., Noten A.F.H., Horzinek M.C., Spaan W.J.M. Sequence of mouse hepatitis virus A59 mRNA 2: Indications for RNA recombination between coronavirus and influenza C virus. Virology. 1988;166:415–422. doi: 10.1016/0042-6822(88)90512-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Makino S., Keck J.G., Stohlman S.A., Lai M.M.C. High frequency RNA recombination of murine coronaviruses. J. Virol. 1986;57:729–737. doi: 10.1128/jvi.57.3.729-737.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Makino S., Stohlman S.A., Lai M.M.C. Vol. 83. 1986. Leader sequences of murine coronavirus mRNAs can be freely reassorted: Evidence for the role of free leader RNA in transcription; pp. 4204–4208. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Makino S., Fleming J.O., Keck J.G., Stohlman S.A., Lai M.M.C. Vol. 84. 1987. RNA recombination of coronaviruses: Localization of neutralizing epitopes and neuropathogenic determinants on the carboxyl terminus of peplomers; pp. 6567–6571. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Martin J.P., Koehren F., Rannou J.-J., Kirn A. Temperature-sensitive mutants of mouse hepatitis virus type 3 (MHV-3): Isolation, biochemical and genetic characterization. Arch. Virol. 1988;100:147–160. doi: 10.1007/BF01487679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Melton D.A., Krieg P.A., Rebagliati M.R., Maniatis T., Zinn K., Green M.R. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 1984;12:7035–7056. doi: 10.1093/nar/12.18.7035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pachuk C.J., Bredenbeek P.J., Zoltick P.W., Spaan W.J.M., Weiss S.R. Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus, strain A59. Virology. 1989;171:141–148. doi: 10.1016/0042-6822(89)90520-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sawicki D.L., Kaariainen L., Lambek C., Gomatos P.J. Mechanism for control of synthesis of semliki forest virus 26S and 42S RNA. J. Virol. 1978;25:19–27. doi: 10.1128/jvi.25.1.19-27.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sawicki D.L., Sawicki S.G., Keranen S., Kaariainen L. Specific sindbis virus-coded function for minus-strand RNA synthesis. J. Virol. 1981;39:348–358. doi: 10.1128/jvi.39.2.348-358.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sawicki S.G., Sawicki D.L., Kaariainen L., Keranen S. A sindbis virus mutant temperature-sensitive in the regulation of minus-strand RNA synthesis. Virology. 1981;115:161–172. doi: 10.1016/0042-6822(81)90098-2. [DOI] [PubMed] [Google Scholar]
  38. Sawicki S.G., Sawicki D.L. Coronavirus minus strand synthesis and effect of cyclohexamide on coronavirus RNA synthesis. J. Virol. 1986;57:328–334. doi: 10.1128/jvi.57.1.328-334.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sawicki S.G., Sawicki D.L. Coronavirus transcription: Subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis. J. Virol. 1990;64:1050–1056. doi: 10.1128/jvi.64.3.1050-1056.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sethna P.B., Hung S.-L., Brian D.A. Vol. 86. 1989. Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons; pp. 5626–5630. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shieh C.-K., Lee H.-J., Yokomori K., LaMonica N., Makino S., Lai M.M.C. Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J. Virol. 1989;63:3729–3736. doi: 10.1128/jvi.63.9.3729-3736.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Siddell S. Coronavirus JHM: Coding assignments of subgenomic mRNA. J. Gen. Virol. 1983;64:113–125. doi: 10.1099/0022-1317-64-1-113. [DOI] [PubMed] [Google Scholar]
  43. Skinner M.A., Siddell S.G. Coronavirus JHM: Nucleotide sequence of the mRNA that encodes nucleocapsid protein. Nucleic Acids Res. 1983;11:5045–5054. doi: 10.1093/nar/11.15.5045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Soe L.H., Shieh C.-K., Baker S.C., Chang M.-F., Lai M.M.C. Sequence and translation of the murine coronavirus 5′ end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J. Virol. 1987;61:3968–3976. doi: 10.1128/jvi.61.12.3968-3976.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Spaan W., Delius H., Skinner M., Armstrong J., Rottier P., Smeekens S., Van der Zeijst B.A.M., Siddell S.G. Coronavirus mRNA synthesis involves fusion of noncontiguous sequences. EMBO J. 1983;2:1839–1844. doi: 10.1002/j.1460-2075.1983.tb01667.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Spaan W.J.M., Cavanagh D., Horzinek M.C. Coronaviruses: Structure and genome expression. J. Gen. Virol. 1988;69:2939–2952. doi: 10.1099/0022-1317-69-12-2939. [DOI] [PubMed] [Google Scholar]
  47. Stohlman S.A., Baric R.S., Nelson G.N., Soe L.H., Welter L.M., Deans R.K. Specific interaction between the coronavirus leader RNA and nucleocapsid protein. J. Virol. 1988;62:4288–4295. doi: 10.1128/jvi.62.11.4288-4295.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sturman L., Holmes K. The novel glycoproteins of coronaviruses. Trends Biochem. Sci. 1985;10:17–20. [Google Scholar]
  49. Sturman L.S., Holmes K.V., Behnke J. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J. Virol. 1980;33:449–462. doi: 10.1128/jvi.33.1.449-462.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Wege H., Muller A., Ter Meulen V. Genomic RNA of the murine Coronavirus JHM. J. Gen. Virol. 1978;41:217–227. doi: 10.1099/0022-1317-41-2-217. [DOI] [PubMed] [Google Scholar]
  51. Yokomori K., LaMonica N., Makino S., Shieh C.-K., Lai M.M.C. Biosynthesis, structure, and biological activities of envelope protein gp65 of murine coronavirus. Virology. 1989;173:683–691. doi: 10.1016/0042-6822(89)90581-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Virology are provided here courtesy of Elsevier

RESOURCES